from urllib.parse import urljoin, urlparse
有趣的是，Infigratinib最初于2021年获批用于胆管癌，后因适应症开发策略调整而主动撤回。如今，其有望在ACH赛道迎来“第二春”。基于其疗效和口服便利性，BridgeBio在今年的JPM大会上预测，该药Infigratinib将占据ACH治疗市场50%以上的份额。
，推荐阅读旺商聊官方下载获取更多信息
Последние новости
DENVER—The US Air Force's new Sentinel intercontinental ballistic missile is on track for its first test flight next year, military officials reaffirmed this week.
Like all such hypoxia-addled-brain thoughts, it was a successful tweet.